Mobile

A Comparative Double Blind Placebo-Controlled Study of Immunogenicity and Safety of two doses 10 ^5 and 10^7 CFU of SC599 oral vaccine, a Live Attenuated Shigella dysenteriae 1 vaccine strain in Hea...

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-001915-78

A Comparative Double Blind Placebo-Controlled Study of Immunogenicity and Safety of two doses 10 ^5 and 10^7 CFU of SC599 oral vaccine, a Live Attenuated Shigella dysenteriae 1 vaccine strain in Healthy Human Adult Volunteers »

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of the trial is to compare the immunogenicity of two doses 10^5 and 10^7 CFU of SC599 vaccine candidate to a placebo.

Critère d'inclusion

  • Healthy Volunteers

Liens